THOMAS A BUCHHOLZ to Radiation-Sensitizing Agents
This is a "connection" page, showing publications THOMAS A BUCHHOLZ has written about Radiation-Sensitizing Agents.
Connection Strength
0.713
-
MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Oncotarget. 2016 11 01; 7(44):71660-71672.
Score: 0.122
-
Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. Oncotarget. 2014 Jul 15; 5(13):5076-86.
Score: 0.104
-
Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation. Stem Cells Transl Med. 2014 Jul; 3(7):849-56.
Score: 0.103
-
Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells. Breast Cancer Res Treat. 2012 Jul; 134(2):495-510.
Score: 0.090
-
MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Clin Cancer Res. 2011 Sep 01; 17(17):5638-48.
Score: 0.085
-
Overcoming radiation resistance in inflammatory breast cancer. Cancer. 2010 Jun 01; 116(11 Suppl):2840-5.
Score: 0.078
-
The role of locoregional therapy in inflammatory breast cancer. Semin Oncol. 2008 Feb; 35(1):78-86.
Score: 0.067
-
130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain. Clin Cancer Res. 2007 Mar 15; 13(6):1868-74.
Score: 0.063